Lung cancer and regular use of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs

Pharmacoepidemiology and Drug Safety

Volumn 17, Issue 4, 2008, Pages 322-327

  Kelly, Judith P ^a   Coogan, Patricia ^a   Strom, Brian L ^b   Rosenberg, Lynn ^a  

^a BOSTON UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Aspirin; Epidemiology; Lung cancer; Nonsteroidal anti inflammatory drugs

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; CANCER RISK; CIGARETTE SMOKING; CONTROLLED STUDY; EDUCATIONAL STATUS; FEMALE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; INTERVIEW; LOGISTIC REGRESSION ANALYSIS; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT DURATION; ADOLESCENT; CASE CONTROL STUDY; CLINICAL TRIAL; INCIDENCE; LUNG TUMOR; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; OUTCOME ASSESSMENT; PHARMACOEPIDEMIOLOGY; SMOKING; STATISTICAL MODEL; UNITED STATES;

ADOLESCENT; ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CASE-CONTROL STUDIES; FEMALE; HUMANS; INCIDENCE; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PHARMACOEPIDEMIOLOGY; SMOKING; UNITED STATES;

EID: 42149085117     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1532     Document Type: Article

References (25)

1. http://www.cancer.org/downloads/STT/CAFF2007PWSecured.pdf [accessed 4/25/ 07].
2. Brown JR, DuBois RN. Cyclooxygenase-2 in lung carcinogenesis and chemoprevention. Chest 2004; 125: 134S-140S.
3. Brabender J, Park J, Metzger R, et al. Prognostic significance of cyclooxygenase 2 mRNA expression in non-small cell lung cancer (review). Ann Surg 2002; 235: 440-443.
4. Chan AT, Ogino S, Fuchs CS. Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. N Engl J Med 2007; 356: 2131-2142.
5. Thun M, Henley S, Patrono C. Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistics, pharmacologic, and clinical issues (Review). J Natl Cancer Inst 2002; 94: 252-266.
6. Harris RE, Beebe-Donk J, Doss H, et al. Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade (Review). Oncol Rep 2005; 13: 559-583.
7. González-Pérez A, García Rodríguez LA, López-Ridaura R. Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis. BMC Cancer 2003; http://www.biomedcentral.com/1471-2407/3/28 [accessed 6/4/07].
8. http://www.bu.edu/slone/SloneSurvey/AnnualRpt/SloneSurveyRepon2OO6.pdf [accessed 7/5/07].
9. Peto R, Gray R, Collins R, et al. Randomised trial of prophylactic daily aspirin in British male doctors. Br Med J 1988; 296: 313-316.
10. Lee I, Manson C, Hennekens C. Low-dose aspirin and risk of cancer: the Physicians Health Study [abstract]. Am J Epidemiol 1995; 141: S28.
11. Cook N, Lee I, Gaziano JM, et al. Low-dose aspirin in the primary prevention of cancer. The Women's Health Study: a randomized controlled trial. JAMA 2005; 294: 47-55.
12. Adhmedkhanov A, Toniolo P, Zeleniuch-Jacquotte A, et al. Aspirin and lung cancer in women. Br J Cancer 2002; 87: 49-53.
13. Moysich K, Menezes R, Ronsani A, et al. Regular aspirin use and lung cancer risk. BMC Cancer 2002; 2: 1-7.
14. Hernández-Díaz S, García Rodríguez LA. Nonsteroidal anti-inflammatory drugs and risk of lung cancer. Int J Cancer 2007; 120: 1565-1572.
15. Muscat J, Chen S, Richie J, et al. Risk of lung carcinoma among users of nonsteroidal antiinflammatory drugs. Cancer 2003; 97: 1732-1736.
16. Schreinemachers D, Everson R. Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology 1994; 5: 138-146.
17. Holick C, Michaud D, Leitzmann M, et al. Aspirin use and lung cancer in men. Br J Cancer 2003; 89: 1705-1708.
18. Thun M, Namboodiri M, Calle E, et al. Aspirin use and risk of fatal cancer. Cancer Res 1993; 53: 1322-1327.
19. Friis S, Sorensen HT, McLaughlin JK. A population-based cohort study of the risk of colorectal and other cancers among users of low-dose aspirin. Br J Cancer 2003; 88: 684-688.
20. Paganini-Hill A, Chao A, Ross R, et al. Aspirin use and chronic diseases: a cohort of the elderly. Br Med J 1989; 299: 1247-1250.
21. Ratnasinghe L, Graubard BI, Kahle L, et al. Aspirin use and mortality from cancer in a prospective cohort study. Anticancer Res 2004; 24: 3177-3184.
22. Rosenberg L. Nonsteroidal anti-inflammatory drugs and cancer. Prev Med 1995; 24: 107-109.
23. Langman M, Cheng K, Gilman E, et al. Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database. Br Med J 2000; 320: 1642-1646.
24. Harris RE, Beebe-Donk J, Schuller HM. Chemoprevention of lung cancer by non-steroidal anti-inflammatory drugs among cigarette smokers. Oncol Rep 2002; 9: 693-695.
25. Alberg AJ, Samet JM. Epidemiology of lung cancer. Chest 2003; 123: 21-49.